Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= ARIH1 ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: ARIH1 * **<color #00a2e8>Official Name</color>**: ariadne RBR E3 ubiquitin protein ligase 1 * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=25820|25820]] * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/Q9Y4X5|Q9Y4X5]] * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=ARIH1&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ARIH1|Open PubMed]] * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/605624|Open OMIM]] == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: N/A * **<color #00a2e8>UniProt Summary</color>**: E3 ubiquitin-protein ligase, which catalyzes ubiquitination of target proteins together with ubiquitin- conjugating enzyme E2 UBE2L3 (PubMed:15236971, PubMed:21532592, PubMed:24076655, PubMed:27565346, PubMed:23707686). Acts as an atypical E3 ubiquitin-protein ligase by working together with cullin-RING ubiquitin ligase (CRL) complexes and initiating ubiquitination of CRL substrates: associates with CRL complexes and specifically mediates addition of the first ubiquitin on CRLs targets (PubMed:27565346). The initial ubiquitin is then elongated by CDC34/UBE2R1 and UBE2R2 (PubMed:27565346). E3 ubiquitin-protein ligase activity is activated upon binding to neddylated cullin- RING ubiquitin ligase complexes (PubMed:24076655, PubMed:27565346). Plays a role in protein translation in response to DNA damage by mediating ubiquitination of EIF4E2, the consequences of EIF4E2 ubiquitination are however unclear (PubMed:25624349). According to a report, EIF4E2 ubiquitination leads to promote EIF4E2 cap-binding and protein translation arrest (PubMed:25624349). According to another report EIF4E2 ubiquitination leads to its subsequent degradation (PubMed:14623119). Acts as the ligase involved in ISGylation of EIF4E2 (PubMed:17289916). {ECO:0000269|PubMed:14623119, ECO:0000269|PubMed:15236971, ECO:0000269|PubMed:17289916, ECO:0000269|PubMed:21532592, ECO:0000269|PubMed:23707686, ECO:0000269|PubMed:24076655, ECO:0000269|PubMed:25624349, ECO:0000269|PubMed:27565346}. <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |IBR| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |Lewy body| |ubiquitin-like protein transferase activity| |Cul4A-RING E3 ubiquitin ligase complex| |Cul2-RING ubiquitin ligase complex| |ubiquitin conjugating enzyme binding| |Cul3-RING ubiquitin ligase complex| |Cajal body| |SCF ubiquitin ligase complex| |positive regulation of proteasomal ubiquitin-dependent protein catabolic process| |positive regulation of ubiquitin-dependent protein catabolic process| |positive regulation of proteasomal protein catabolic process| |ubiquitin ligase complex| |positive regulation of proteolysis involved in cellular protein catabolic process| |regulation of proteasomal ubiquitin-dependent protein catabolic process| |positive regulation of cellular protein catabolic process| |regulation of ubiquitin-dependent protein catabolic process| |regulation of proteasomal protein catabolic process| |positive regulation of protein catabolic process| |regulation of proteolysis involved in cellular protein catabolic process| |ubiquitin protein ligase activity| |ubiquitin-protein transferase activity| |regulation of cellular protein catabolic process| |nuclear body| |ubiquitin protein ligase binding| |protein polyubiquitination| |positive regulation of proteolysis| |positive regulation of cellular catabolic process| |regulation of protein catabolic process| |positive regulation of catabolic process| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |protein catabolic process| |protein ubiquitination| |regulation of proteolysis| |protein modification by small protein conjugation| |regulation of cellular catabolic process| |zinc ion binding| |cellular macromolecule catabolic process| |protein modification by small protein conjugation or removal| |regulation of catabolic process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |proteolysis| |positive regulation of cellular protein metabolic process| |positive regulation of protein metabolic process| |organic substance catabolic process| |cellular catabolic process| </modal> \\ === CRISPR Data === <button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='primary' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> ^Screen^Score^ |[[:results:exp278|CVT-10216 0.1μM R06 exp278]]|-3.02| |[[:results:exp281|Disulfiram 4.3μM R06 exp281]]|-2.69| |[[:results:exp239|PFI-2 4μM R05 exp239]]|-2.42| |[[:results:exp291|LLY-284 2.6μM R06 exp291]]|-2.32| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-2.02| |[[:results:exp283|Glyphosate 1000μM R06 exp283]]|-2.02| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.02| |[[:results:exp177|Apcin 25μM plus proTAME 2μM R04 exp177]]|-1.93| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|-1.93| |[[:results:exp248|UM0131023 0.05μM R05 exp248]]|-1.86| |[[:results:exp264|Arsenate 40μM R06 exp264]]|-1.83| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|-1.82| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|-1.82| |[[:results:exp70|INK128 0.2μM R02 exp70]]|-1.79| |[[:results:exp280|Daidzin 10μM R06 exp280]]|-1.77| |[[:results:exp343|Centrinone 0.5μM R07 exp343]]|-1.76| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|-1.75| |[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|-1.74| |[[:results:exp290|LLY-283 2.6μM R06 exp290]]|-1.73| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|1.8| |[[:results:exp59|UMK57 1μM R01 exp59]]|3.02| </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> ^Gene^Correlation^ |[[:human genes:m:mapk14|MAPK14]]|0.469| |[[:human genes:u:ube2l3|UBE2L3]]|0.457| |[[:human genes:c:ccdc101|CCDC101]]|0.445| |[[:human genes:a:atf7ip|ATF7IP]]|0.433| |[[:human genes:c:cbfb|CBFB]]|0.423| |[[:human genes:m:mllt1|MLLT1]]|0.416| |[[:human genes:u:ube3a|UBE3A]]|0.415| |[[:human genes:f:fnta|FNTA]]|0.405| |[[:human genes:t:taf5l|TAF5L]]|0.402| |[[:human genes:m:med23|MED23]]|0.402| |[[:human genes:r:rnmt|RNMT]]|0.401| |[[:human genes:a:aars|AARS]]|0.401| </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: 676/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|24/28| |blood|25/28| |bone|24/26| |breast|30/33| |central nervous system|53/56| |cervix|4/4| |colorectal|15/17| |esophagus|13/13| |fibroblast|1/1| |gastric|16/16| |kidney|18/21| |liver|18/20| |lung|70/75| |lymphocyte|15/16| |ovary|24/26| |pancreas|23/24| |peripheral nervous system|11/16| |plasma cell|15/15| |prostate|1/1| |skin|20/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|27/29| |uterus|5/5| </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 2088 * **<color #00a2e8>Expression level (log2 read counts)</color>**: 7.15 <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='ARIH1 Expression in NALM6 Cells: 7.15'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2026/01/07 22:36by 127.0.0.1